Hence, the current study set out to evaluate the specific effects of BMSC-EVs on macrophage polarization during PAH and the mechanisms related to the miR-200b/PDE1A/PKA axis, to ultimately provide a promising therapeutic target against PAH. Here, PDE1A is linked to pulmonary arterial hypertension.